Roth MKM Sticks to Their Buy Rating for Turning Point Brands (TPB)
Roth MKM analyst Nick Anderson maintained a Buy rating on Turning Point Brands (TPB – Research Report) today and set a price target of $70.00.
Nicotine Replacement Therapies Market Forecast to Reach $7.52 Billion by 2032: Growing Shift Towards Personalised Nicotine Replacement Therapies
GSK, Pfizer, Johnson & Johnson, Reynolds American, Novartis, Imperial Brands, Cipla Limited, British American Tobacco, Merck ...
Five contrarian stocks that could surprise the Indian stock market in 2025
We highlight five contrarian stocks to add to your watchlist—companies that have the potential to surprise the market and ...
Philip Morris: Shift To Smoke-Free Sparks Steady Dividend Growth
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...
J.P. Morgan Keeps Their Hold Rating on British American Tobacco (BATS)
In a report released today, Celine Pannuti CFA from J.P. Morgan maintained a Hold rating on British American Tobacco (BATS – Research Report).